About Nath Bio-Genes (India) Ltd
Nath Bio-Genes (India) is engaged in the business of Production, Processing, and Marketing of Hybrid and GM Seeds. The Company has a product range of Field crops, Vegetable crops and Plant Nutrient Supplements.
Founded
1993
CEO
Satish Kagliwal
Employees
451
HQ
Mumbai, India
Finished Products
1Seeds-Commercial
₹821.44Cr2Agricultural Products-Traded
₹401.71Cr3Sale of Products
₹45.60Cr4Other Operating Income
₹5.83CrRaw Materials
1Purchases
₹32.40CrAbout Nath Bio-Genes (India) Ltd
Nath Bio-Genes (India) is engaged in the business of Production, Processing, and Marketing of Hybrid and GM Seeds. The Company has a product range of Field crops, Vegetable crops and Plant Nutrient Supplements.
Founded:1993
CEO:Satish Kagliwal
Employees:451
HQ:Mumbai, India
Finished Products
1Seeds-Commercial
₹821.44Cr2Agricultural Products-Traded
₹401.71Cr3Sale of Products
₹45.60Cr4Other Operating Income
₹5.83CrRaw Materials
1Purchases
₹32.40CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹204
52W Low
₹126
Volume4.81K
Avg VolumeN/A
Beta0.88
Dividend Yield1.31%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
7.52x
Valuation
P/B Ratio
0.43x
Valuation
EPS
₹20.35
Valuation
Dividend Yield
1.31%
Valuation
ROE
5.32%
Profitability
ROCE
6.87%
Profitability
Revenue by Segment
Contribution & growth by business line
Agriculture Activities
+7.6%87.5%
₹319.3 Cr
Trading Activity
+27.5%12.5%
₹45.6 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
98.8%
International
1.2%
India98.8%
Outside India1.2%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.20x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
6.6%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.